Sexually Transmitted Infections (STIs) Market Report 2026

The sexually transmitted infections (stis) market size has grown rapidly in recent years. It will grow from $71.28 billion in 2025 to $79.48 billion in 2026 at a compound annual growth rate (CAGR) of 11.5%. The growth in the historic period can be attributed to rising prevalence of STIs, limited access to early diagnostic tools, growing government awareness campaigns, urbanization and lifestyle changes, increasing patient visits to sexual health clinics.

The sexually transmitted infections (stis) market size is expected to see rapid growth in the next few years. It will grow to $126.99 billion in 2030 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to adoption of advanced molecular diagnostics, growth of at-home STI testing, increasing integration with telemedicine platforms, enhanced funding for STI prevention programs, rise of AI-assisted diagnostic tools. Major trends in the forecast period include development of rapid point-of-care STI testing, increasing use of home-based STI test kits, rise in vaccine development for STIs, growing adoption of combination diagnostic platforms, increasing public awareness campaigns for STI prevention.

The rise in government initiatives aimed at increasing awareness of sexually transmitted infections is expected to drive the growth of the sexually transmitted infections (STIs) market in the coming years. A government initiative refers to a program or policy introduced to achieve specific objectives and address identified challenges. Governments implement various initiatives to prevent, manage, and treat STIs, including funding public awareness campaigns, providing vaccines to prevent certain infections, and offering free or low-cost screening and testing services. For example, in April 2023, Springfield-Greene County Health, a US-based public health department, announced the launch of a Disease Intervention Specialist (DIS) program in partnership with the Missouri Department of Health and Senior Services (Missouri DHSS) to address the increasing spread of STIs in Greene County. The DIS program specialists, primarily focusing on syphilis and HIV, contact individuals who test positive, connect them with treatment options, and assist in notifying and reaching others who may have been exposed. Therefore, the expansion of government initiatives is supporting the growth of the sexually transmitted infections (STIs) market.

Leading companies in the sexually transmitted infections (STIs) market are focusing on developing innovative products based on fluorescent PCR technology to strengthen their competitive position. Fluorescent PCR (polymerase chain reaction) is a molecular diagnostic technique used to detect and quantify specific DNA sequences within biological samples. For instance, in March 2023, Jiangsu Bioperfectus Technologies Co. Ltd., a China-based provider of molecular diagnostic solutions, launched two new PCR kits: the Mycoplasma Hominis Real-Time PCR Kit and the Treponema Pallidum Real-Time PCR Kit. These kits offer a comprehensive PCR-based solution for the early diagnosis of sexually transmitted infections that affect a large population. The BioPerfectus Mycoplasma Hominis Real-Time PCR Kit uses fluorescent PCR technology to detect Mycoplasma hominis in samples such as male urethral swabs, female cervical or vaginal swabs, and urine. The BioPerfectus Treponema Pallidum Real-Time PCR Kit is designed to identify treponema pallidum nucleic acid in human serum and plasma samples.

In February 2023, Caraway Health, a US-based digital healthcare provider focused on Generation Z, partnered with Ash Wellness Inc. for an undisclosed amount. This collaboration aims to address the rising incidence of sexually transmitted infections among university students. Through the partnership, Generation Z individuals are provided with tools to prioritize and manage their sexual health on their own terms. Ash Wellness Inc. is a US-based company offering remote diagnostic solutions, including at-home HIV and STI testing services.

Major companies operating in the sexually transmitted infections (stis) market are Pfizer Inc., Johnson & Johnson, Roche Holdings AG, Merck & Co Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb, Astra Zeneca Pharmaceuticals LP, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Co. Ltd., Hetero Drugs Ltd., Eisai Co. Ltd., Boehringer Ingelheim Group, Sun Pharmaceutical Industries Ltd., Lupin Limited, Dr. Reddy's Laboratories, Wockhardt Ltd., Zydus Lifescience Ltd., Glenmark Pharmaceuticals Ltd., Cipla Ltd., Torrent Pharmaceuticals Ltd., Otsuka Pharmaceutical Co. Ltd.

North America was the largest region in the sexually transmitted infection (STIs) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sexually transmitted infections (stis) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the sexually transmitted infections (stis) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have increased costs in the sexually transmitted infections market by raising prices for imported diagnostic kits, antibiotics, antiviral drugs, and laboratory reagents used in STI detection and treatment. Hospitals, specialty clinics, and point-of-care testing facilities in Asia-Pacific and emerging markets are most affected due to dependence on international medical supply chains. These cost pressures can slow access to rapid testing and advanced antiviral therapies. However, tariffs are driving domestic production of diagnostics and pharmaceuticals, strengthening long-term accessibility in the STIs market.

The sexually transmitted infections (stis) market research report is one of a series of new reports that provides sexually transmitted infections (stis) market statistics, including sexually transmitted infections (stis) industry global market size, regional shares, competitors with a sexually transmitted infections (stis) market share, detailed sexually transmitted infections (stis) market segments, market trends and opportunities, and any further data you may need to thrive in the sexually transmitted infections (stis) industry. This sexually transmitted infections (stis) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Sexually transmitted infections (STIs), also called sexually transmitted diseases (STDs), are illnesses caused by viruses, bacteria, or parasites that are transmitted from one person to another through sexual contact. These infections can spread through vaginal, anal, and oral sex, as well as through skin-to-skin contact.

The main types of sexually transmitted infections include human immunodeficiency virus (HIV), human papillomavirus (HPV), gonorrhea, syphilis, and others. Human immunodeficiency virus (HIV) is a virus that attacks the immune system by destroying a type of white blood cell that helps the body fight infections. Treatments include antibiotics and antivirals, administered in settings such as laboratory testing and point-of-care (POC) testing. Routes of administration include oral, parenteral, and others, and these treatments are used in hospitals, specialty clinics, homecare settings, and more.

The sexually transmitted infections (STIs) market consists of revenues earned by entities by providing services such as treatment, testing, awareness programs and diagnosis. The market value includes the value of related goods sold by the service provider or included within the service offering. The sexually transmitted infections (STIs) market also includes the sales of treatments such as testing kits, vaccines and medication. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.